版本:
中国

BRIEF-Regen Biopharma restructures management stock compensation

March 15 Regen Biopharma Inc

* Regen Biopharma restructures management stock compensation

* Management team has agreed to collectively cancel 16.5 million common shares and 15 million series a preferred shares

* Company has created a new class of stock, series M preferred which does not trade publicly

* Management team will receive replacement shares for publicly traded shares they cancelled Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐